Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 2950-2958

  Strong, David W ^a   Thackray, Larissa B ^a   Smith, Tom J ^b   Virgin, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DONALD DANFORTH PLANT SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH RATE; IN VIVO STUDY; LETHALITY; MOLECULAR CLONING; MOUSE; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RESIDUE ANALYSIS; REVERSE GENETICS; VIRUS ATTENUATION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; CELL LINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NOROVIRUS; PROTEIN STRUCTURE, TERTIARY; VIRULENCE; VIRUS REPLICATION;

MIRIDAE; MURINE NOROVIRUS; MUS; NOROVIRUS;

EID: 84857964291     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07038-11     Document Type: Article

References (65)

1. Atmar RL, Estes MK. 2006. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. North Am. 35:275-290.
2. Atmar RL, et al. 2008. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 14:1553-1557.
3. Bailey D, et al. 2010. Functional analysis of RNA structures present at the 3= extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence. J. Virol. 84:2859 -2870.
4. Bailey D, Thackray LB, Goodfellow IG. 2008. A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J. Virol. 82:7725-7728.
5. Barron EL, et al. 2011. Diversity of murine norovirus strains isolated from asymptomatic mice of different genetic backgrounds within a single U.S. research institute. PLoS One 6:e21435.
6. Bertolotti-Ciarlet A, White LJ, Chen R, Prasad BV, Estes MK. 2002. Structural requirements for the assembly of Norwalk virus-like particles. J. Virol. 76:4044-4055.
7. Cadwell K, et al. 2010. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141: 1135-1145.
8. Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. 2008. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog. 4:e1000236.
9. Chachu KA, et al. 2008. Antibody is critical for the clearance of murine norovirus infection. J. Virol. 82:6610-6617.
10. Changotra H, et al. 2009. Type I and type II interferons inhibit the translation of murine norovirus proteins. J. Virol. 83:5683-5692.
11. Chaudhry Y, Skinner MA, Goodfellow IG. 2007. Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J. Gen. Virol. 88:2091-2100.
12. Chen SY, et al. 2009. Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clin. Infect. Dis. 48:849-855.
13. Daughenbaugh KF, Wobus CE, Hardy ME. 2006. VPg of murine norovirus binds translation initiation factors in infected cells. Virol. J. 3:1-7.
14. Donaldson EF, Lindesmith LC, LoBue AD, Baric RS. 2010. Viral shapeshifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 8:231-241.
15. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443- 450.
16. Glass PJ, et al. 2000. Norwalk virus open reading frame 3 encodes a minor structural protein. J. Virol. 74:6581- 6591.
17. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:1776 -1785.
18. Goodfellow I, et al. 2005. Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO Rep. 6:968 -972.
19. Govindasamy L, Hueffer K, Parrish CR, Agbandje-McKenna M. 2003. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants. J. Virol. 77:12211-12221.
20. Graham DY, et al. 1994. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170:34-43.
21. Guenet JL. 2005. Assessing the genetic component of the susceptibility of mice to viral infections. Brief. Funct. Genomic. Proteomic. 4:225-240.
22. Gustavsson L, Andersson LM, Lindh M, Westin J. 2011. Excess mortality following community-onset norovirus enteritis in the elderly. J. Hosp. Infect. 79:27-31.
23. Harrington PR, Vinje J, Moe CL, Baric RS. 2004. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 78:3035-3045.
24. Henderson KS. 2008. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab. Anim. 37:314 -320.
25. Hsu CC, Riley LK, Livingston RS. 2007. Molecular characterization of three novel murine noroviruses. Virus Genes 34:147-155.
26. Hsu CC, Riley LK, Wills HM, Livingston RS. 2006. Persistent infection with and serologic cross-reactivity of three novel murine noroviruses. Comp. Med. 56:247-251.
27. Huang P, et al. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strainspecific patterns. J. Infect. Dis. 188:19 -31.
28. Hueffer K, et al. 2003. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J. Virol. 77:1718 -1726.
29. Hutson AM, Atmar RL, Graham DY, Estes MK. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 185:1335-1337.
30. Kahan SM, et al. 2011. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology 421:202-210.
31. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575- 1578.
32. Katpally U, et al. 2010. High-resolution cryo-electron microscopy structures of murine norovirus 1 and rabbit hemorrhagic disease virus reveal marked flexibility in the receptor binding domains. J. Virol. 84:5836- 5841.
33. Katpally U, Wobus CE, Dryden K, Virgin HW, Smith TJ. 2008. The structure of antibody neutralized murine norovirus and unexpected differences to virus like particles. J. Virol. 82:2079 -2088.
34. Kontou M, et al. 2005. Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. J. Virol. 79: 10931-10943.
35. Lindesmith LC, et al. 2008. Mechanisms of GII 4 norovirus persistence in human populations. PLoS Med. 5:e31.
36. Lopez-Bueno A, et al. 2008. Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism. J. Virol. 82:1195- 1203.
37. Marshall JK, Thabane M, Borgaonkar MR, James C. 2007. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin. Gastroenterol. Hepatol. 5:457- 460.
38. McCartney SA, et al. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4:e1000108.
39. McFadden N, et al. 2011. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 7:e1002413.
40. Medici MC, Abelli LA, Dodi I, Dettori G, Chezzi C. 2010. Norovirus RNA in the blood of a child with gastroenteritis and convulsions-a case report. J. Clin. Virol. 48:147-149.
41. Meraz MA, et al. 1996. Targeted disruption of the Stat 1 gene in mice reveals unexpected physiologic specificity of the JAK-STAT signalling pathway. Cell 84:431- 442.
42. Mumphrey SM, et al. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81:3251-3263.
43. Nelson CD, Palermo LM, Hafenstein SL, Parrish CR. 2007. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies. Virology 361: 283-293.
44. Nilsson M, et al. 2003. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J. Virol. 77: 13117-13124.
45. Obinata K, et al. 2010. Norovirus encephalopathy in a previously healthy child. Pediatr. Infect. Dis. J. 29:1057-1059.
46. Patel MM, Hall AJ, Vinje J, Parashar UD. 2009. Noroviruses: a comprehensive review. J. Clin. Virol. 44:1- 8.
47. Phillips G, Tam CC, Rodrigues LC, Lopman B. 2010. Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiol. Infect. 138:1454 -1458.
48. Rubio MP, Lopez-Bueno A, Almendral JM. 2005. Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor. J. Virol. 79:11280 -11290.
49. Rydell GE, et al. 2009. Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 19:309 -320.
50. Schwartz S, et al. 2011. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 117:5850 -5856.
51. Simmonds P, et al. 2008. Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic. Acids Res. 36:2530 -2546.
52. Smith D, McFadden N, Blundell RJ, Meredith A, Simmonds P. 2012. Diversity of murine norovirus in wild-rodent populations: speciesspecific associations suggest an ancient divergence. J. Gen. Virol. 93:259- 266.
53. Sosnovtsev SV, et al. 2006. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 80:7816 -7831.
54. Stuart RL, et al. 2010. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII 3. Pediatr. Infect. Dis. J. 29:644-647.
55. Tarakanova VL, et al. 2005. Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J. Virol. 79:14668 -14679.
56. Taube S, et al. 2009. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 83:4092- 4101.
57. Taube S, et al. 2010. High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. J. Virol. 84:5695-5705.
58. Thackray LB, et al. 2007. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 81:10460 -10473.
59. Turcios-Ruiz RM, et al. 2008. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J. Pediatr. 153:339- 344.
60. van Asten L, et al. 2011. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology 22:336- 343.
61. Ward VK, et al. 2007. Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc. Natl. Acad. Sci. U. S. A. 104:11050 -11055.
62. Westhoff TH, et al. 2009. Chronic norovirus infection in renal transplant recipients. Nephrol. Dial. Transplant. 24:1051-1053.
63. Wobus CE, et al. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:e432.
64. Wobus CE, Thackray LB, Virgin HW. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80:5104- 5112.
65. Zheng DP, et al. 2006. Norovirus classification and proposed strain nomenclature. Virol. 346:312-323.